Sung JJ, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther. 2009;29(9):938-946.
[3]
Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017;390(10094):613-624.
[4]
Barkun AN, Bardou M, Kuipers EJ, et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010;152(2):101-113.
[5]
Kochhar R, Sood A, Wig JD, et al. Acute peptic ulcer bleeding: a randomized comparison of acetylsalicylic acid and drug-naive patients. J Gastroenterol Hepatol. 2011;26(5):849-855.
[6]
Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol. 2012;107(3):345-360.
[7]
Sreedharan A, Martin J, Leontiadis GI, et al. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2010;(7):CD005415.
[8]
Graham DY, Opekun AR, Fischer J, et al. Nonsteroidal anti-inflammatory drug damage to the gastrointestinal tract. Curr Ther Res Clin Exp. 2003;64(9):641-651.
[9]
Katelaris PH, Seow F, Bell C, et al. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut. 1993;34(8):1032-1037.
[10]
Hsu PI, Lai KH, Lin CK, et al. A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication. Am J Gastroenterol. 2005;100(11):2387-2392.